کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
1968587 1538864 2016 6 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Development and validation of an immunosensor for monocyte chemotactic protein 1 using a silicon photonic microring resonator biosensing platform
ترجمه فارسی عنوان
توسعه و اعتبار سنجی ایمونوسنسور برای پروتئین 1 مونوسیت chemotactic با استفاده از رزناتور میکروحلقه فوتونیک سیلیکونی
کلمات کلیدی
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی زیست شیمی
چکیده انگلیسی


• A MCP-1 immunosensor was developed on a silicon photonic microring resonator platform.
• Rapid detection of MCP-1 was achieved in human serum samples.
• The assay had limits of blank and detection of 0.3 and 0.5 pg/mL, respectively, and a working range of 84.3 to 1582.1 pg/mL.
• The sensor was validated across a number of suggested clinical cut-off values.

ObjectivesWe report the development of an optical immunosensor for the detection of monocyte chemotactic protein 1 (MCP-1) in serum samples. MCP-1 is a cytokine that is an emerging biomarker for several diseases/disorders, including ischemic cardiomyopathy, fibromyalgia, and some cancers.Design and methodsThe detection of MCP-1 was achieved by performing a sandwich immunoassay on a silicon photonic microring resonator sensor platform. The resonance wavelengths supported by microring sensors are responsive to local changes in the environment accompanying biomarker binding. This technology offers a modularly multiplexable approach to detecting analyte localization in an antibody-antigen complex at the sensor surface.ResultsThe immunosensor allowed the rapid detection of MCP-1 in buffer and spiked human serum samples. An almost 2 order of magnitude linear range was observed, between 84.3 and 1582.1 pg/mL and the limits of blank and detection were determined to be 0.3 and 0.5 pg/mL, respectively. The platform's ability to analyze MCP-1 concentrations across a clinically-relevant concentration range was demonstrated.ConclusionsA silicon photonic immunosensor technology was applied to the detection of clinically-relevant concentrations of MCP-1. The performance of the sensor was validated through a broad dynamic range and across a number of suggested clinical cut-off values. Importantly, the intrinsic scalability and rapidity of the technology makes it readily amenable to the simultaneous detection of multiplexed biomarker panels, which is particularly needed for the clinical realization of inflammatory diagnostics.

Figure optionsDownload as PowerPoint slide

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Clinical Biochemistry - Volume 49, Issues 1–2, January 2016, Pages 121–126
نویسندگان
, , ,